Tanım

Women’s health refers to the branch of medicine that focuses on the treatment and diagnosis of diseases and conditions that affect a woman’s physical and emotional well-being. The global women’s health therapeutics market is set to increase by US$ 15.08 billion from 2021 ile 2027, representing a compound annual growth rate (CAGR) ile ilgili 5.1% tahmin dönemi boyunca.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2017-2020 ve tahmin 2027 covering key market aspects like sales value for women’s health therapeutics. The global women’s health therapeutics market is segmented on the basis of disease, ve bölge. On the basis of disease, the global women’s health therapeutics market has been segmented into breast cancer, postmenopausal osteoporosis, menopause, endometriosis, and polycystic ovary syndrome (PCOS). The breast cancer segment held the largest revenue share in 2020. In terms of geography, the global women’s health therapeutics market has been segmented into Asia Pacific, Avrupa, Kuzey Amerika, and Rest of the World (RoW).

The global women’s health therapeutics market is highly competitive. Top players covered in Global Women’s Health Therapeutics Market Study are AbbVie Inc., Amgen Inc., Asahi Kasei Corporation, AstraZeneca plc, Bayer AG, Bristol Myers Squibb (BMS), Eisai Co. Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Merck & ortak. Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited.

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the women’s health therapeutics market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Disease: breast cancer, postmenopausal osteoporosis, menopause, endometriosis, and polycystic ovary syndrome (PCOS)
Bölge: Asya Pasifik, Avrupa, Kuzey Amerika, and Rest of the World (RoW)
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2017 ile 2027

Paydaşlar için Temel Faydalar

– Get a comprehensive picture of the global women’s health therapeutics market
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

1. Pazar tanımı
2. Araştırma metodolojisi
3. Piyasa verileri ve görünüm
3.1 Pazar büyüklüğü tahminleri
3.2 Tahmin etmek
4. Women’s health therapeutics market by disease
4.1 Breast cancer
4.2 Postmenopausal osteoporosis
4.3 Menopause
4.4 Endometriosis
4.5 Polycystic ovary syndrome (PCOS)
5. Women’s health therapeutics market by region
5.1 Asya Pasifik
5.2 Avrupa
5.3 Kuzey Amerika
5.4 Dünyanın Geri Kalanı (RoW)
6. Şirket profilleri
6.1 AbbVie Inc.
6.2 Amgen Inc.
6.3 Asahi Kasei Corporation
6.4 AstraZeneca plc
6.5 Bayer AG
6.6 Bristol Myers Squibb (BMS)
6.7 Eisai Co., Ltd..
6.8 Eli Lilly and Company
6.9 F. Hoffmann-La Roche AG
6.10 Merck & Şti., A.Ş..
6.11 Novartis International AG
6.12 Pfizer Inc.
6.13 Sanofi SA.
6.14 Takeda Pharmaceutical Company Limited
7. Ek
7.1 StratejiHelix Hakkında
7.2 Sorumluluk reddi beyanı